Back in November, Apple asked Apple Watch users if they wanted to take part in a study called the Apple Heart Survey being conducted by Apple and Stanford Health. Now, Apple is telling those who opted-in that the study has begun. Tapping on the notification takes participants to the Heart Study app where they must confirm that they are “comfortable” speaking and writing in English, and haven’t been diagnosed with Atrial fibrillation or Atrial flutter. In addition, participants cannot be on blood thinners like Coumadin, Pradaxa, Xarelto, Eliquis and Savaysa.
If the Apple Watch user …